+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Global Hereditary Angioedema Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Hereditary Angioedema Therapeutics Market 2023-2027

  • Report
  • July 2023
  • 156 Pages
  • Global
From
Angioedema - Pipeline Insight, 2024 - Product Thumbnail Image

Angioedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
From
From
Global Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Global Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Global Fibrin Sealants Market 2022-2026 - Product Thumbnail Image

Global Fibrin Sealants Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
Loading Indicator